Innate Immune Agonists
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
11
NCT04645797
A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 19, 2021
Completion: May 7, 2022
Loading map...